Recent Finacing
Recent Raise
ProteinLogic discovers biomarkers and develops diagnostic platforms and products, including ImmiPrint for monitoring tuberculosis antimicrobial chemotherapy treatment response and assays for infection and inflammation.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor